Systemic lupus erythematosus and angiogenesis: clinical aspects and approaches to therapy

Authors:

Abstract
Background. Systemic lupus erythematosus is an autoimmune disease with a multifaceted pathogenesis. Objective. To evaluate the role of angiogenesis in the diagnosis and treatment of systemic lupus erythematosus. Materials and methods. A systematic review of the scientific literature from 2000 to 2025 was conducted using PubMed, Scopus, and Web of Science databases. Results. Angiogenesis and microvascular endothelial damage play a role in the pathogenesis of systemic lupus erythematosus. Vascular endothelial growth factor, hepatocyte growth factor, stromal cell-derived factor-1, placental growth factor, chemokines, and interleukin-17F are elevated in patients with systemic lupus erythematosus, especially during the active phase of the disease. Measuring serum MFG-E8 levels in patients with systemic lupus erythematosus may be useful for assessing the risk of cerebrovascular disease or neuropsychiatric manifestations associated with these diseases. Angiogenesis can also be assessed using the in vitro Matrigel vascular tube formation assay and nailfold capillaroscopy. Patients with systemic lupus erythematosus experience accelerated atherosclerosis, significantly increasing the risk of cardiovascular complications. Endothelial dysfunction, one of the first stages of atherogenesis, is detected in patients with systemic lupus erythematosus even in the absence of a history of cardiovascular disease. It has been established that testing for impaired angiogenesis has demonstrated high efficacy in the diagnosis of systemic lupus erythematosus. Vitamin D, exosomes, and mesenchymal stem cells can be used to treat systemic lupus erythematosus. Approaches to systemic lupus erythematosus therapy that take into account impaired angiogenesis are a promising direction. Conclusion. Research into impaired angiogenesis offers broad prospects for individualizing diagnostic and therapeutic approaches. However, implementing these methods into clinical practice requires the development of unified standards and large-scale studies at multiple centers.